title: Protocols for assessing radiofrequency interactions with gold nanoparticles and biological systems for non-invasive hyperthermia cancer therapy.
abstract: Cancer therapies which are less toxic and invasive than their existing counterparts are highly desirable. The use of RF electric-fields that penetrate deep into the body, causing minimal toxicity, are currently being studied as a viable means of non-invasive cancer therapy. It is envisioned that the interactions of RF energy with internalized nanoparticles (NPs) can liberate heat which can then cause overheating (hyperthermia) of the cell, ultimately ending in cell necrosis. In the case of non-biological systems, we present detailed protocols relating to quantifying the heat liberated by highly-concentrated NP colloids. For biological systems, in the case of in vitro experiments, we describe the techniques and conditions which must be adhered to in order to effectively expose cancer cells to RF energy without bulk media heating artifacts significantly obscuring the data. Finally, we give a detailed methodology for in vivo mouse models with ectopic hepatic cancer tumors.
authors.affiliation: Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center.
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Corr
authors.forename: Brandon T
authors.initials: BT
authors.lastname: Cisneros
authors.forename: Leila
authors.initials: L
authors.lastname: Green
authors.forename: Mustafa
authors.initials: M
authors.lastname: Raoof
authors.forename: Steven A
authors.initials: SA
authors.lastname: Curley
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D003102:Colloids / Q000008:administration & dosage* / Q000737:chemistry; D003972:Diathermy / Q000295:instrumentation / Q000379:methods*; D006046:Gold / Q000008:administration & dosage* / Q000737:chemistry; D006801:Humans; D006979:Hyperthermia, Induced / Q000295:instrumentation / Q000379:methods*; D008113:Liver Neoplasms / Q000628:therapy*; D053768:Metal Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D023041:Xenograft Model Antitumor Assays
chemical_list: D003102:Colloids; D006046:Gold
references.citation: J Colloid Interface Sci. 2011 Jun 1;358(1):47-53
references.pmid: 21429501
references.citation: Ther Deliv. 2011 Oct;2(10):1325-30
references.pmid: 22826886
references.citation: IEEE Trans Biomed Eng. 2011 Jul;58(7):2002-12
references.pmid: 21402506
references.citation: Cancer. 2007 Dec 15;110(12):2654-65
references.pmid: 17960610
references.citation: J Exp Ther Oncol. 2008;7(4):313-26
references.pmid: 19227011
references.citation: Nano Lett. 2006 Jun;6(6):1261-8
references.pmid: 16771591
references.citation: Nanomedicine. 2012 Oct;8(7):1096-105
references.pmid: 22349096
references.citation: Surgery. 2010 Aug;148(2):319-24
references.pmid: 20541785
references.citation: Cancer. 2010 Jul 1;116(13):3285-93
references.pmid: 20564640
references.citation: J Nanobiotechnology. 2008 Jan 30;6:2
references.pmid: 18234109
references.citation: Nanoscale. 2012 Jul 7;4(13):3945-53
references.pmid: 22622412
references.citation: J Phys Chem C Nanomater Interfaces. 2012 Nov 15;116(45):24380-24389
references.pmid: 23795228